IPIX / NBIO RN I look at IPIX different than you. IPIX has been through phase 2 with Brilacidin (for different indication). The outcomes were good but they need cash to go to phase 3 (long story). Patients tolerated with little side effects. IPIX is asking the FDA to allow a trial with patents soon, I consider that much more advanced than a possible phase 1 down the line for NBIO. Both companies have little debt and sure NVIO a smaller share structure is good but if Brilacidin proves effective the market cap is not an issue.
Market Data 
Markets 
AI
